China Healthcare Summit
November 2-3, 2023 | Shanghai

November 7-8, 2023 | Digital

BioCentury and BayHelix’s China Healthcare Summit marks its 10th Anniversary with a return to Shanghai, gathering C-level executives from Asia and beyond for renewed cross-border collaboration and discussion. Innovation from Asian biotechs is on the rise, presenting new opportunities for partnership and investment. China Summit is specifically tailored for C-level executives and VCs, with a strategic program offering a first-hand look at the innovation, business, and policy transformations taking place in China and Asia. Don’t miss this opportunity to join your peers in-person in Shanghai Nov. 2-3, and for an additional 2 days of virtual meetings from Nov. 7-8, to explore transformative opportunities with global reach.

---

Written by Richard Daverman, PhD. Click a link below to view the mailing archive as if it had been sent to you. 2012-10-31 01:30 Charles River Labs Pays $27 Million for China Lab Animals Provider and more... 2012-10-28 01:30 Week in Review: Fosun Pharma's Hong Kong IPO Raises $512 Million 2012-10-27 01:30 US Medical Device Makers Target China's 2nd and 3rd Tier Markets 2012-10-26 01:30 Kindstar Diagnostics to Offer BG Medicine's Cardiac Test 2012-10-25 01:30 MicuRx Lands $9.6 Million to Fund China Trials of Antibiotic and more... 2012-10-24 01:30 AstraZeneca Signs $150 Million China Deal with Ironwood Pharma 2012-10-23 01:30 ChinaBioÔö£éÔö¼?½ Leadership Retreat Brings 120 Senior Life Science Executives Together to "Rethink China" and more... 2012-10-21 01:30 Week in Review: Fosun Pharma to Spend $300 Million from Hong Kong IPO on M&A 2012-10-20 01:30 Complete Genomics, Soon to Be a BGI Subsidiary, Wins Partial Victory in Illumina Suit and more... 2012-10-19 01:30 Legend Capital Invests in Innovative China Medical Device Companies 2012-10-18 01:30 Half of Fosun Pharma's Hong Kong IPO Will Fund Acquisitions and more... 2012-10-17 01:30 WuXi AppTec Opens China's First GMP Biologics Facility and more... 2012-10-16 01:30 Shanghai Starts New Antibody Institute; Names US Researcher as Director 2012-10-14 01:30 The Week in Review: SFDA Drug Approvals Drop in 2011 2012-10-13 01:30 Fosun Pharma's $600 Million Hong Kong IPO: Is it a Steal? and more... 2012-10-12 01:30 SFDA Releases 2011 Drug and Clinical Trial Approval Report 2012-10-11 01:30 Tianyin Pharma Says $25 Million Production Facility Nearly Complete 2012-10-10 01:30 LoneStar Heart Raises $20 Million in Round Led by Hong Kong PE Firm 2012-10-09 01:30 Cephasonics Signs China Medical Device Distribution Deal with Excelpoint 2012-10-07 01:30 The Week in Review: Fosun Pharma Schedules $600 Million Hong Kong IPO 2012-10-06 01:30 RuiYi In-Licenses Cancer/Anti-Inflammatory mAb and more... 2012-10-05 01:30 China Biotech May Soon Sell Vaccine to International Aid Groups 2012-10-04 01:30 Vital Therapies Secures $16 Million for Trial of Artificial Liver Device and more... 2012-10-02 01:30 Sanofi Signs MOU for Rare Disease Collaboration with Sinopharm and more...   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz Not a ChinaBio®Today Subscriber? Here's what you get with a paid subscription to ChinaBio® Today: Website access to all current articles and commentary Full access to over 2000 archived articles on the biotech industry Get started now for as little as $20... ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC